ISRCTN ISRCTN98321871
DOI https://doi.org/10.1186/ISRCTN98321871
Protocol serial number 71887897
Sponsor Alzheimer's Society (UK)
Funder Alzheimer's Society
Submission date
05/07/2005
Registration date
26/08/2005
Last edited
24/08/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Alistair Burns
Scientific

Wythenshawe Hospital
Manchester
M23 9LT
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymWHIFF-AD
Study objectivesAromatherapy is as effective as standard treatment for agitation in Alzheimer's disease
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedAlzheimer's disease
InterventionAromatherapy versus standard treatment
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Aromatherapy
Primary outcome measure(s)

Reduction in agitation

Key secondary outcome measure(s)

Side effect profile

Completion date01/02/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration150
Key inclusion criteriaAlzheimer's disease with agitation
Key exclusion criteriaFailure to meet inclusion criteria
Date of first enrolment01/02/2006
Date of final enrolment01/02/2009

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Wythenshawe Hospital
Manchester
M23 9LT
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2011 Yes No